Entacapone
Top View
- Rasagiline NDC 0378- -93 Dispense in a Tight, Light-Resistant Mesylate Equivalent to 0.5 Mg 1270 Container As Defined in the USP of Rasagiline
- Comtan, INN-Entacapone
- Parkinson's Disease with End-Of-Dose Motor Fluctuations: Opicapone
- Carbidopa-Levodopa-Entacapone (Stalevo)
- Parkinson's Treatment “Tips & Pearls”
- PSP: Some Answers
- Levodopa/Carbidopa/Entacapone Orion, INN-Levodopa, Carbidopa
- Appendix B - Product Name Sorted by Applicant
- Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
- Safinamide (Xadago) Reference Number: ERX.NPA.45 Effective Date: 09.01.17 Last Review Date: 02.21 Line of Business: Commercial, Medicaid Revision Log
- PUBLIC SUMMARY DOCUMENT Product: RASAGILINE, Tablet, 1 Mg, Azilect® Sponsor: Lundbeck Australia Pty Ltd Date of PBAC Consideration: July 2011
- Second Quarter 2019 Update: Changes to the Highmark Drug Formularies
- Therapeutic Drug Class
- ENTAPONE 1. Product Name 2. Qualitative and Quantitative
- Opioid Codrugs for Pain Management
- Parkinson's Disease Medications
- Levodopa/Carbidopa/Entacapone Orion, INN-Levodopa, Carbidopa
- Practical Guidelines for Management of Parkinson Disease